标题
CD133 expression associated with poor prognosis in ovarian cancer
作者
关键词
-
出版物
MODERN PATHOLOGY
Volume 25, Issue 3, Pages 456-464
出版商
Springer Nature
发表日期
2011-11-11
DOI
10.1038/modpathol.2011.170
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma
- (2011) Po Zhao et al. CANCER SCIENCE
- Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3
- (2010) Li Ma et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
- (2010) L Hu et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis
- (2010) Roberto Pallini et al. CANCER
- Cancer Stem Cells and Self-renewal
- (2010) C. A. O'Brien et al. CLINICAL CANCER RESEARCH
- Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer
- (2010) Michael et al. Frontiers in Bioscience-Landmark
- Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis
- (2010) Rola Al Dhaybi et al. MODERN PATHOLOGY
- Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma
- (2010) Sasaki ONCOLOGY REPORTS
- CD133 antigen expression in ovarian cancer
- (2009) Gabriella Ferrandina et al. BMC CANCER
- CD133 expression in rectal cancer after preoperative chemoradiotherapy
- (2009) Motohiro Kojima et al. CANCER SCIENCE
- Serous Carcinogenesis in the Fallopian Tube
- (2009) Elke Jarboe et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment
- (2009) Riccardo Di Fiore et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer
- (2009) David Horst et al. JOURNAL OF PATHOLOGY
- Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
- (2009) Chun-Yan Li et al. Journal of Translational Medicine
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
- (2008) F. Zeppernick et al. CLINICAL CANCER RESEARCH
- Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma
- (2008) W. Song et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
- (2008) Keren Levanon et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
- Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
- (2008) K E Tagscherer et al. ONCOGENE
- Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions
- (2008) Richard Birnie et al. GENOME BIOLOGY
- Expression of CD133-1 and CD133-2 in ovarian cancer
- (2007) G. FERRANDINA et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started